
Spero Therapeutics, Inc.
SPROHealthcare|Biotechnology|US
$1.03
+0.01 (+0.98%)
Tangible Book / Share
$0.76
Graham Number
$1.48
Cash / Share
$0.88
Ownership Breakdown
80.9%
Float
58.2M
Shares Outstanding
47.1M
Float Shares
Major Holders (7)
Combined: 33.8%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| GSK PLC | Corporation | 16.40% | 9,190,606 | Mar 28, 2025 | 13D/G |
| Amin Nathoo | HC, IN | 2.90% | 1,615,469 | Aug 14, 2025 | 13D/G |
| Anson Funds Management LP | IA, PN | 2.90% | 1,615,469 | Aug 14, 2025 | 13D/G |
| Anson Management GP LLC | HC, OO | 2.90% | 1,615,469 | Aug 14, 2025 | 13D/G |
| Anson Advisors Inc. | FI, CO | 2.90% | 1,615,469 | Aug 14, 2025 | 13D/G |
| Tony Moore | HC, IN | 2.90% | 1,615,469 | Aug 14, 2025 | 13D/G |
| Moez Kassam | HC, IN | 2.90% | 1,615,469 | Aug 14, 2025 | 13D/G |
Insider Trades (100)
Last 4 quarters: 1,162,000 acquired · 245,374 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Zack Debra | Chief Medical Officer | Aug 3, 2026 | AWARD | 324,675 | $1.54 | $500.0K | Form 4 |
| Zack Debra | Chief Medical Officer | Aug 3, 2026 | AWARD | 162,311 | — | — | Form 4 |
| Zack Debra | Aug 3, 2026 | OTHER | 0 | — | — | Form 4 | |
| Deshpande Milind | director | Jun 23, 2026 | AWARD | 10,000 | — | — | Form 4 |
| Deshpande Milind | director | Jun 23, 2026 | AWARD | 20,000 | $2.15 | $43.0K | Form 4 |
| Tregoning Kathleen | director | Jun 23, 2026 | AWARD | 10,000 | — | — | Form 4 |
| Tregoning Kathleen | director | Jun 23, 2026 | AWARD | 20,000 | $2.15 | $43.0K | Form 4 |
| Smith Cynthia | director | Jun 23, 2026 | AWARD | 10,000 | — | — | Form 4 |
| Smith Cynthia | director | Jun 23, 2026 | AWARD | 20,000 | $2.15 | $43.0K | Form 4 |
| VINK PATRICK V.J.J. | director | Jun 23, 2026 | AWARD | 10,000 | — | — | Form 4 |
| VINK PATRICK V.J.J. | director | Jun 23, 2026 | AWARD | 20,000 | $2.15 | $43.0K | Form 4 |
| THOMAS FRANK E | director | Jun 23, 2026 | AWARD | 10,000 | — | — | Form 4 |
| THOMAS FRANK E | director | Jun 23, 2026 | AWARD | 20,000 | $2.15 | $43.0K | Form 4 |
| Jackson Scott Thomas | director | Jun 23, 2026 | AWARD | 10,000 | — | — | Form 4 |
| Jackson Scott Thomas | director | Jun 23, 2026 | AWARD | 20,000 | $2.15 | $43.0K | Form 4 |
| Pottage John C Jr | director | Jun 23, 2026 | AWARD | 10,000 | — | — | Form 4 |
| Pottage John C Jr | director | Jun 23, 2026 | AWARD | 20,000 | $2.15 | $43.0K | Form 4 |
| Rajavelu Esther | See Remarks | May 4, 2026 | SELL | 25,240 | $2.51 | $63.4K | Form 4 |
| Rajavelu Esther | See Remarks | Feb 6, 2026 | SELL | 37,101 | $2.36 | $87.6K | Form 4 |
| Rajavelu Esther | See Remarks | Feb 6, 2026 | SELL | 50,816 | $2.36 | $119.9K | Form 4 |
| Keutzer Timothy | Chief Operating Officer | Feb 6, 2026 | SELL | 18,652 | $2.36 | $44.0K | Form 4 |
| Keutzer Timothy | Chief Operating Officer | Feb 2, 2026 | AWARD | 68,000 | — | — | Form 4 |
| Keutzer Timothy | Chief Operating Officer | Feb 2, 2026 | SELL | 18,891 | $2.20 | $41.6K | Form 4 |
| Keutzer Timothy | Chief Operating Officer | Feb 3, 2026 | SELL | 24,224 | $2.14 | $51.8K | Form 4 |
| Keutzer Timothy | Chief Operating Officer | Feb 4, 2026 | SELL | 3,471 | $2.24 | $7.8K | Form 4 |
| Keutzer Timothy | Chief Operating Officer | Feb 2, 2026 | AWARD | 137,000 | $2.23 | $305.5K | Form 4 |
| Rajavelu Esther | See Remarks | Feb 2, 2026 | AWARD | 249,000 | — | — | Form 4 |
| Rajavelu Esther | See Remarks | Feb 2, 2026 | SELL | 18,442 | $2.20 | $40.6K | Form 4 |
| Rajavelu Esther | See Remarks | Feb 2, 2026 | AWARD | 498,000 | $2.23 | $1.1M | Form 4 |
| Rajavelu Esther | See Remarks | Nov 7, 2025 | SELL | 40,270 | $2.37 | $95.4K | Form 4 |
| Mahadevia Ankit | director | Aug 28, 2025 | SELL | 6,572 | $1.97 | $12.9K | Form 4 |
| Keutzer Timothy | Chief Operating Officer | Aug 28, 2025 | SELL | 1,695 | $1.97 | $3.3K | Form 4 |
| Mahadevia Ankit | director | Jun 12, 2025 | AWARD | 20,000 | — | — | Form 4 |
| Deshpande Milind | director | Jun 12, 2025 | AWARD | 20,000 | — | — | Form 4 |
| Jackson Scott Thomas | director | Jun 12, 2025 | AWARD | 20,000 | — | — | Form 4 |
| VINK PATRICK V.J.J. | director | Jun 12, 2025 | AWARD | 20,000 | — | — | Form 4 |
| Pottage John C Jr | director | Jun 12, 2025 | AWARD | 20,000 | — | — | Form 4 |
| Smith Cynthia | director | Jun 12, 2025 | AWARD | 20,000 | — | — | Form 4 |
| THOMAS FRANK E | director | Jun 12, 2025 | AWARD | 20,000 | — | — | Form 4 |
| Tregoning Kathleen | director | Jun 12, 2025 | AWARD | 20,000 | — | — | Form 4 |
| Rajavelu Esther | See Remarks | May 2, 2025 | AWARD | 185,000 | — | — | Form 4 |
| Keutzer Timothy | Chief Operating Officer | Feb 3, 2025 | AWARD | 266,139 | — | — | Form 4 |
| Keutzer Timothy | Chief Operating Officer | Feb 5, 2025 | SELL | 3,974 | $0.78 | $3.1K | Form 4 |
| Keutzer Timothy | Chief Operating Officer | Feb 5, 2025 | SELL | 27,643 | $0.78 | $21.6K | Form 4 |
| Keutzer Timothy | Chief Operating Officer | Feb 5, 2025 | SELL | 24,920 | $0.78 | $19.4K | Form 4 |
| Rajavelu Esther | CFO & CBO | Feb 3, 2025 | AWARD | 100,000 | — | — | Form 4 |
| Rajavelu Esther | CFO & CBO | Feb 5, 2025 | SELL | 20,689 | $0.78 | $16.1K | Form 4 |
| Rajavelu Esther | CFO & CBO | Feb 3, 2025 | AWARD | 266,139 | — | — | Form 4 |
| Shukla Sath | CEO & President | Feb 3, 2025 | AWARD | 751,407 | — | — | Form 4 |
| Shukla Sath | CEO & President | Feb 5, 2025 | SELL | 6,139 | $0.78 | $4.8K | Form 4 |
| Shukla Sath | CEO & President | Feb 5, 2025 | SELL | 42,786 | $0.78 | $33.4K | Form 4 |
| Shukla Sath | CEO & President | Feb 5, 2025 | SELL | 106,408 | $0.78 | $83.0K | Form 4 |
| Mahadevia Ankit | director | Feb 5, 2025 | SELL | 13,959 | $0.78 | $10.9K | Form 4 |
| Mahadevia Ankit | director | Feb 5, 2025 | SELL | 55,260 | $0.78 | $43.1K | Form 4 |
| Rajavelu Esther | CFO & CBO | Nov 7, 2024 | SELL | 23,351 | $1.31 | $30.6K | Form 4 |
| Rajavelu Esther | CFO & CBO | Nov 8, 2024 | SELL | 17,245 | $1.30 | $22.4K | Form 4 |
| Mahadevia Ankit | director | Aug 27, 2024 | SELL | 5,912 | $1.35 | $8.0K | Form 4 |
| Keutzer Timothy | Chief Operating Officer | Aug 27, 2024 | SELL | 2,213 | $1.35 | $3.0K | Form 4 |
| Shukla Sath | CEO & President | Aug 27, 2024 | SELL | 2,757 | $1.35 | $3.7K | Form 4 |
| Shukla Sath | CEO and President | Aug 2, 2024 | SELL | 14,800 | $1.32 | $19.5K | Form 4 |
| Shukla Sath | CEO and President | Aug 5, 2024 | SELL | 17,641 | $1.31 | $23.1K | Form 4 |
| Deshpande Milind | director | May 29, 2024 | AWARD | 20,000 | — | — | Form 4 |
| Jackson Scott Thomas | director | May 29, 2024 | AWARD | 20,000 | — | — | Form 4 |
| Mahadevia Ankit | director | May 29, 2024 | AWARD | 20,000 | — | — | Form 4 |
| VINK PATRICK V.J.J. | director | May 29, 2024 | AWARD | 20,000 | — | — | Form 4 |
| Tregoning Kathleen | director | May 29, 2024 | AWARD | 20,000 | — | — | Form 4 |
| Smith Cynthia | director | May 29, 2024 | AWARD | 20,000 | — | — | Form 4 |
| THOMAS FRANK E | director | May 29, 2024 | AWARD | 20,000 | — | — | Form 4 |
| Pottage John C Jr | director | May 29, 2024 | AWARD | 20,000 | — | — | Form 4 |
| Keutzer Timothy | Chief Operating Officer | Feb 1, 2024 | AWARD | 239,731 | — | — | Form 4 |
| Keutzer Timothy | Chief Operating Officer | Feb 2, 2024 | SELL | 30,971 | $1.36 | $42.1K | Form 4 |
| Mahadevia Ankit | director | Feb 2, 2024 | SELL | 63,795 | $1.37 | $87.4K | Form 4 |
| JOSEPH TAMARA L | Chief Legal Officer | Feb 1, 2024 | AWARD | 239,731 | — | — | Form 4 |
| JOSEPH TAMARA L | Chief Legal Officer | Feb 2, 2024 | SELL | 30,906 | $1.37 | $42.3K | Form 4 |
| HAMED KAMAL | Chief Medical Officer | Feb 1, 2024 | AWARD | 239,731 | — | — | Form 4 |
| HAMED KAMAL | Chief Medical Officer | Feb 2, 2024 | SELL | 28,075 | $1.37 | $38.5K | Form 4 |
| Rajavelu Esther | See Remarks | Feb 1, 2024 | AWARD | 119,866 | — | — | Form 4 |
| Shukla Sath | director, officer: CEO and President | Feb 1, 2024 | AWARD | 679,501 | — | — | Form 4 |
| Shukla Sath | director, officer: CEO and President | Feb 2, 2024 | SELL | 30,901 | $1.37 | $42.3K | Form 4 |
| Shukla Sath | director, officer: CEO and President | Feb 5, 2024 | SELL | 45,093 | $1.45 | $65.4K | Form 4 |
| Tregoning Kathleen | director | Jan 2, 2024 | AWARD | 35,604 | $1.52 | $54.1K | Form 4 |
| Rajavelu Esther | See Remarks | Nov 13, 2023 | AWARD | 300,000 | — | — | Form 4 |
| Rajavelu Esther | Nov 6, 2023 | OTHER | 0 | — | — | Form 4 | |
| Pottage John C Jr | director | Oct 5, 2023 | AWARD | 20,000 | — | — | Form 4 |
| Smith Cynthia | director | Oct 5, 2023 | AWARD | 20,000 | — | — | Form 4 |
| THOMAS FRANK E | director | Oct 5, 2023 | AWARD | 20,000 | — | — | Form 4 |
| Deshpande Milind | director | Oct 5, 2023 | AWARD | 20,000 | — | — | Form 4 |
| Tregoning Kathleen | director | Oct 5, 2023 | AWARD | 20,000 | — | — | Form 4 |
| VINK PATRICK V.J.J. | director | Oct 5, 2023 | AWARD | 20,000 | — | — | Form 4 |
| Jackson Scott Thomas | director | Oct 5, 2023 | AWARD | 20,000 | — | — | Form 4 |
| Mahadevia Ankit | director | Oct 5, 2023 | AWARD | 20,000 | — | — | Form 4 |
| HAMED KAMAL | Chief Medical Officer | Sep 13, 2023 | SELL | 39,496 | $1.27 | $50.2K | Form 4 |
| Keutzer Timothy | Chief Development Officer | Aug 28, 2023 | SELL | 1,854 | $1.26 | $2.3K | Form 4 |
| JOSEPH TAMARA L | Chief Legal Officer | Aug 28, 2023 | SELL | 1,854 | $1.26 | $2.3K | Form 4 |
| Mahadevia Ankit | director | Aug 28, 2023 | SELL | 9,040 | $1.26 | $11.4K | Form 4 |
| Shukla Sath | director, officer: CEO and President | Aug 28, 2023 | SELL | 1,854 | $1.26 | $2.3K | Form 4 |
| Shukla Sath | director, officer: CEO and President | Aug 29, 2023 | SELL | 4,163 | $1.30 | $5.4K | Form 4 |
| Shukla Sath | director, officer: CEO and President | Aug 1, 2023 | AWARD | 266,000 | — | — | Form 4 |
| DiPalma Stephen J. | Jul 15, 2023 | OTHER | 0 | — | — | Form 4 | |
| HAMED KAMAL | Chief Medical Officer | Jun 12, 2023 | AWARD | 140,000 | — | — | Form 4 |